Merit Medical [MMSI] vs Avantor [AVTR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Merit Medical wins in 10 metrics, Avantor wins in 9 metrics, with 0 ties. Merit Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Merit Medical Avantor Better
P/E Ratio (TTM) 41.98 13.27 Avantor
Price-to-Book Ratio 3.29 1.45 Avantor
Debt-to-Equity Ratio 55.14 67.49 Merit Medical
PEG Ratio -4.27 -0.37 Merit Medical
EV/EBITDA 19.09 12.13 Avantor
Profit Margin (TTM) 8.31% 10.31% Avantor
Operating Margin (TTM) 12.30% 7.63% Merit Medical
EBITDA Margin (TTM) 12.30% 7.63% Merit Medical
Return on Equity 8.60% 11.73% Avantor
Return on Assets (TTM) 4.19% 3.24% Merit Medical
Free Cash Flow (TTM) $182.76M $692.00M Avantor
1-Year Return -12.58% -45.86% Merit Medical
Price-to-Sales Ratio (TTM) 3.42 1.37 Avantor
Enterprise Value $5.38B $12.93B Avantor
EV/Revenue Ratio 3.75 1.94 Avantor
Gross Profit Margin (TTM) 48.24% 32.92% Merit Medical
Revenue per Share (TTM) $24 $10 Merit Medical
Earnings per Share (Diluted) $1.97 $1.01 Merit Medical
Beta (Stock Volatility) 0.58 0.98 Merit Medical
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Merit Medical vs Avantor Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Merit Medical-4.23%-6.20%-11.04%-17.00%-13.71%-17.78%
Avantor-1.03%-6.23%6.26%-2.19%-8.84%-36.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Merit Medical-12.58%50.73%72.37%241.25%544.88%586.76%
Avantor-45.86%-31.56%-45.22%-7.59%-7.59%-7.59%

News Based Sentiment: Merit Medical vs Avantor

Merit Medical

News based Sentiment: MIXED

October brought a significant leadership change alongside strong Q2 earnings and a stock price decline, creating a mixed investment narrative. While the company demonstrates positive financial momentum and technological advancements, the stock's performance and insider selling introduce uncertainty, making this a moderately important month for investors.

View Merit Medical News Sentiment Analysis

Avantor

News based Sentiment: MIXED

October was a pivotal month for Avantor, with a blend of positive developments like the tariff announcement and board appointment, offset by institutional selling, index removal, and an upcoming earnings report with projected declines. The mixed signals create a complex investment narrative, making it a moderately significant month for the company.

View Avantor News Sentiment Analysis

Performance & Financial Health Analysis: Merit Medical vs Avantor

MetricMMSIAVTR
Market Information
Market Cap i$4.96B$9.56B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i669,40010,561,390
90 Day Avg. Volume i683,7539,230,570
Last Close$78.99$13.40
52 Week Range$78.12 - $111.45$10.82 - $26.14
% from 52W High-29.13%-48.74%
All-Time High$111.45 (Jan 27, 2025)$44.37 (Sep 20, 2021)
% from All-Time High-29.13%-69.80%
Growth Metrics
Quarterly Revenue Growth0.13%-0.01%
Quarterly Earnings Growth-0.09%-0.30%
Financial Health
Profit Margin (TTM) i0.08%0.10%
Operating Margin (TTM) i0.12%0.08%
Return on Equity (TTM) i0.09%0.12%
Debt to Equity (MRQ) i55.1467.49
Cash & Liquidity
Book Value per Share (MRQ)$25.13$9.22
Cash per Share (MRQ)$5.77$0.66
Operating Cash Flow (TTM) i$239.96M$681.80M
Levered Free Cash Flow (TTM) i$190.72M$688.84M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Merit Medical vs Avantor

MetricMMSIAVTR
Price Ratios
P/E Ratio (TTM) i41.9813.27
Forward P/E i22.2911.86
PEG Ratio i-4.27-0.37
Price to Sales (TTM) i3.421.37
Price to Book (MRQ) i3.291.45
Market Capitalization
Market Capitalization i$4.96B$9.56B
Enterprise Value i$5.38B$12.93B
Enterprise Value Metrics
Enterprise to Revenue i3.751.94
Enterprise to EBITDA i19.0912.13
Risk & Other Metrics
Beta i0.580.98
Book Value per Share (MRQ) i$25.13$9.22

Financial Statements Comparison: Merit Medical vs Avantor

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MMSIAVTR
Revenue/Sales i$355.35M$1.58B
Cost of Goods Sold i$183.33M$1.05B
Gross Profit i$172.02M$534.90M
Research & Development i$22.48MN/A
Operating Income (EBIT) i$42.06M$147.40M
EBITDA i$77.83M$230.80M
Pre-Tax Income i$37.96M$85.70M
Income Tax i$7.81M$21.20M
Net Income (Profit) i$30.15M$64.50M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MMSIAVTR
Cash & Equivalents i$395.53M$315.70M
Total Current Assets i$958.64M$2.28B
Total Current Liabilities i$196.82M$2.03B
Long-Term Debt i$808.22M$3.28B
Total Shareholders Equity i$1.43B$6.10B
Retained Earnings i$725.69M$2.27B
Property, Plant & Equipment i$432.99MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MMSIAVTR
Operating Cash Flow i$57.24M$86.60M
Capital Expenditures iN/AN/A
Free Cash Flow i$19.05M$81.30M
Debt Repayment i$0$-31.30M
Common Stock Repurchase iN/A$-4.90M

Short Interest & Institutional Ownership Analysis

MetricMMSIAVTR
Shares Short i3.22M26.01M
Short Ratio i5.912.96
Short % of Float i0.08%0.05%
Average Daily Volume (10 Day) i669,40010,561,390
Average Daily Volume (90 Day) i683,7539,230,570
Shares Outstanding i58.74M680.80M
Float Shares i57.79M663.95M
% Held by Insiders i0.02%0.01%
% Held by Institutions i1.08%1.06%

Dividend Analysis & Yield Comparison: Merit Medical vs Avantor

MetricMMSIAVTR
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A